Mineralys Therapeutics Files Form 4
Ticker: MLYS · Form: 4 · Filed: Apr 16, 2026
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Mineralys Therapeutics filed a Form 4 on 4/15/26 for ownership changes.
AI Summary
On April 15, 2026, Mineralys Therapeutics, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing pertains to the period of report ending April 13, 2026. David Malcom Rodman is listed as the reporting person.
Why It Matters
Form 4 filings indicate changes in stock ownership by company insiders, which can signal their confidence or lack thereof in the company's future performance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of ownership changes and does not inherently indicate significant risk.
Key Players & Entities
- Mineralys Therapeutics, Inc. (company) — Issuer
- David Malcom Rodman (person) — Reporting Person
- 0001933414-26-000076 (filing_id) — SEC Accession Number
- 2026-04-15 (date) — Filing Date
- 2026-04-13 (date) — Period of Report
FAQ
What type of filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
Who is the reporting person?
The reporting person is David Malcom Rodman.
What is the company's CIK number?
The company's CIK number is 0001933414.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-15 at 21:45:26.
What is the period of report for this filing?
The period of report is 2026-04-13.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 16, 2026 by David Malcom Rodman regarding Mineralys Therapeutics, Inc. (MLYS). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.